katayoun samimi-Rad

Dr. katayoun samimi-Rad

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

13 June 2012 in Archives of Virology
Verified
Journal Article
Closed access
PDF file
KSkatayoun samimi-Rad
katayoun samimi-Rad
MTMohsen Nasiri Toosi
Mohsen Nasiri Toosi
AMAli Masoudi-Nejad
Ali Masoudi-Nejad
ANAli Najafi
Ali Najafi
RRRamin Rahimnia
Ramin Rahimnia
FAFreshteh Asgari
Freshteh Asgari

15 October 2014 in Hepatitis Monthly
Verified
Journal Article
Open access
PDF file
LSLeila Pishraft Sabet
Leila Pishraft Sabet
TTTahereh Taheri
Tahereh Taheri
AMArash Memarnejadian
Arash Memarnejadian
TATalat Mokhtari Azad
Talat Mokhtari Azad
FAFatemeh Asgari
Fatemeh Asgari
KSkatayoun samimi-Rad
katayoun samimi-Rad
Immunogenicity of Multi-Epitope DNA and Peptide Vaccine Candidates Based on Core, E2, NS3 and NS5B HCV Epitopes in BALB/c Mice - Hepatitis Monthly - - Kowsar

12 May 2015 in Journal of Medical Virology
Verified
Journal Article
Closed access
PDF file
KSkatayoun samimi-Rad
katayoun samimi-Rad
FSFarzin Sadeghi
Farzin Sadeghi
AAAliakbar Amirzargar
Aliakbar Amirzargar
MEMohamad Reza Eshraghian
Mohamad Reza Eshraghian
SASeyed-Moayed Alavian
Seyed-Moayed Alavian
RRRamin Rahimnia
Ramin Rahimnia

28 October 2014 in Archives of Virology
Verified
Journal Article
Closed access
PDF file
LPLeila Pishraft-Sabet
Leila Pishraft-Sabet
AKAnna D. Kosinska
Anna D. Kosinska
SRSima Rafati
Sima Rafati
ABAzam Bolhassani
Azam Bolhassani
TTTahereh Taheri
Tahereh Taheri
KSkatayoun samimi-Rad
katayoun samimi-Rad

23 January 2013 in Hepatitis Monthly
Verified
Journal Article
Open access
PDF file
KSkatayoun samimi-Rad
katayoun samimi-Rad
FAFreshteh Asgari
Freshteh Asgari
MNMohsen Nasiritoosi
Mohsen Nasiritoosi
AEAbdoulreza Esteghamati
Abdoulreza Esteghamati
AAAzar Azarkeyvan
Azar Azarkeyvan
HNHeléne Norder
Heléne Norder
Background: Hepatitis C is prevalent among thalassemia patients in Iran. It is mainly transfusion mediated, in particular among patients treated before 1996 when blood screening was introduced. Objectives: The current study aimed to investigate why patients still seroconvert to anti-HCV in Iranian thalassemia centers. Patients and Methods: During 2006-2007 sera were sampled from 217 anti-HCV positive thalassemia patients at nine thalassemia centers in Tehran and Amol city, where 34 (16%) patients had been infected after 1996. The HCV subtype could be determined by sequencing and phylogenetic analysis of partial NS5B and/or 5׳NCR-core region in 130 strains. Results: 1a (53%) was predominant followed by 3a (30%), 1b (15%), and one strain each of 2k, 3k and 4a. Phylogenetic analysis revealed 19 clades with up to five strains diverging with less than six nucleotides from each other within subtypes 1a and 3a. Strains in seven clades were from nine patients infected between 1999 and 2005 and similar to strains from eight patients infected before 1996, indicating ongoing transmission at the centers. Further epidemiological investigation revealed that 28 patients infected with strains within the same clade had frequently been transfused at the same shift sitting on the same bed. An additional eight patients with related strains had frequently been transfused simultaneously in the same room. Conclusions: The results suggest nosocomial transmission at these thalassemia centers both before and after the introduction of blood screening. Further training of staff and strict adherence to preventive measures are thus essential to reduce the incidence of new HCV infections. Keywords: Hepatitis C; Thalassemia; Iran